Proton MR Spectroscopy in a 1T Open MR Imaging System

References

1. 1.↵
   1. Payne GS,
   2. Leach MO

   . Applications of magnetic resonance spectroscopy in radiotherapy treatment planning. Br J Radiol 2006;79:S16–26

   Abstract/FREE Full Text
2. 2.↵
   1. Debnam JM,
   2. Ketonen L,
   3. Hamberg LM,
   4. et al

   . Current techniques used for the assessment of intercranial neoplasms. Arch Pathol Lab Med 2007;131:252–60

   PubMed
3. 3.↵
   1. McKnight TR,
   2. Lamborn KR,
   3. Love TD,
   4. et al

   . Correlation of magnetic resonance spectroscopic and growth characteristics within grades II and III gliomas. J Neurosurg 2007;106:660–66

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Sibtain NA,
   2. Howe FA,
   3. Saunders DE

   . The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol 2007;62:109–19

   CrossRefPubMed
5. 5.↵
   1. Moller-Hartmann W,
   2. Herminhaus S,
   3. Krings T,
   4. et al

   . Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371–81

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Perkins TG,
   2. Murdoch JB,
   3. Goss B

   . 1H-MR spectroscopy utilizing a 1T open MR system: initial clinical results. In: International Society for Magnetic Resonance in Medicine 17th Scientific Meeting and Exhibition, Honolulu, Hawaii. April 18–24, 2009
7. 7.↵
   1. Dresner MA,
   2. Andrews T,
   3. Murdoch JB,
   4. et al

   . 1H-MR spectroscopy utilizing a 1T open MR system: multisite clinical test results. In: American Society of Neuroradiology 47th Annual Meeting and NER Foundation Symposium, Vancouver, Canada. May 16–21, 2009
8. 8.↵
   1. Ogg RJ,
   2. Kingsley PB,
   3. Taylor JS

   . WET, a T1 and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994;104:1–10

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Murdoch JB

   . Beyond WET and DRY: optimized pulses for water suppression. In: International Society for Magnetic Resonance in Medicine 4th Annual Meeting, New York, April 27–May 3, 1993
10. 10.↵
    1. Uppot R,
    2. Sahani V,
    3. Hahn P,
    4. et al

    . Effect of obesity on image quality: fifteen year longitudinal study for evaluation of dictated radiology reports. Radiology 2006;240:435–39

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Poptani H,
    2. Gupta R,
    3. Roy R,
    4. et al

    . Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593–603

    Abstract
12. 12.↵
    1. Law M,
    2. Yang S,
    3. Wang H,
    4. et al

    . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24;1989–98
13. 13.↵
    1. Chang L,
    2. Ernst T,
    3. Tornatore C,
    4. et al

    . Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997;48:836–45

    Abstract/FREE Full Text
14. 14.↵
    1. Yoon JH,
    2. Bang OY,
    3. Kim HS

    . Progressive multifocal leukoencephalopathy in AIDS: proton MR spectroscopy patterns of asynchronous lesions confirmed by serial diffusion-weighted imaging and apparent diffusion coefficient mapping. J Clin Neurology 2007;3:200–03

    CrossRef